These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 18849608

  • 1. Fetal hydrops and other variables associated with the fetal hematocrit decrease after the first intrauterine transfusion for red cell alloimmunization.
    Lobato G, Soncini CS.
    Fetal Diagn Ther; 2008; 24(4):349-52. PubMed ID: 18849608
    [Abstract] [Full Text] [Related]

  • 2. Fetal hematocrit decrease after repeated intravascular transfusions in alloimmunized pregnancies.
    Lobato G, Soncini CS.
    Arch Gynecol Obstet; 2007 Dec; 276(6):595-9. PubMed ID: 17572904
    [Abstract] [Full Text] [Related]

  • 3. Relationship between obstetric history and Rh(D) alloimmunization severity.
    Lobato G, Soncini CS.
    Arch Gynecol Obstet; 2008 Mar; 277(3):245-8. PubMed ID: 17763861
    [Abstract] [Full Text] [Related]

  • 4. The effects of serial intravascular transfusions in ascitic/hydropic RhD-alloimmunized fetuses.
    Craparo FJ, Bonati F, Gementi P, Nicolini U.
    Ultrasound Obstet Gynecol; 2005 Feb; 25(2):144-8. PubMed ID: 15660441
    [Abstract] [Full Text] [Related]

  • 5. [Intrauterine transfusión in alloimmunization Rh in México 1987-2008].
    Ramírez-Robles LJ, Gómez-Partida G, Guevara-Rubio G, Velázquez-Gómez L.
    Ginecol Obstet Mex; 2010 Sep; 78(9):469-77. PubMed ID: 21961364
    [Abstract] [Full Text] [Related]

  • 6. Treatment of fetal anemia due to red-cell alloimmunization with intrauterine transfusions in the Netherlands, 1988-1999.
    van Kamp IL, Klumper FJ, Meerman RH, Oepkes D, Scherjon SA, Kanhai HH.
    Acta Obstet Gynecol Scand; 2004 Aug; 83(8):731-7. PubMed ID: 15255845
    [Abstract] [Full Text] [Related]

  • 7. Implementation of routine screening for Kell antibodies: does it improve perinatal survival?
    Kamphuis MM, Lindenburg I, van Kamp IL, Meerman RH, Kanhai HH, Oepkes D.
    Transfusion; 2008 May; 48(5):953-7. PubMed ID: 18248569
    [Abstract] [Full Text] [Related]

  • 8. Predicting Intrauterine Transfusion Interval and Perinatal Outcomes in Alloimmunized Pregnancies: Time-to-Event Survival Analysis.
    Snelgrove JW, D'Souza R, Seaward PGR, Windrim R, Kelly EN, Ryan G.
    Fetal Diagn Ther; 2019 May; 46(6):425-432. PubMed ID: 31195389
    [Abstract] [Full Text] [Related]

  • 9. Management of severe fetal anemia by Doppler measurement of middle cerebral artery: are there other benefits than reducing invasive procedures?
    Garabedian C, Vaast P, Behal H, Coulon C, Duahamel A, Thomas D, Rakza T, Subtil D, Houfflin-Debarge V.
    Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():27-30. PubMed ID: 26142913
    [Abstract] [Full Text] [Related]

  • 10. Fetal middle cerebral artery Doppler to time intrauterine transfusion in red-cell alloimmunization: a randomized trial.
    Dodd JM, Andersen C, Dickinson JE, Louise J, Deussen A, Grivell RM, Voto L, Kilby MD, Windrim R, Ryan G, MCA Doppler Study Group.
    Ultrasound Obstet Gynecol; 2018 Mar; 51(3):306-312. PubMed ID: 28700818
    [Abstract] [Full Text] [Related]

  • 11. A case of severe Rh (D) alloimmunization treated by intensive plasma exchange and high-dose intravenous immunoglobulin.
    Palfi M, Hildén JO, Matthiesen L, Selbing A, Berlin G.
    Transfus Apher Sci; 2006 Oct; 35(2):131-6. PubMed ID: 17045529
    [Abstract] [Full Text] [Related]

  • 12. The severity of immune fetal hydrops is predictive of fetal outcome after intrauterine treatment.
    van Kamp IL, Klumper FJ, Bakkum RS, Oepkes D, Meerman RH, Scherjon SA, Kanhai HH.
    Am J Obstet Gynecol; 2001 Sep; 185(3):668-73. PubMed ID: 11568796
    [Abstract] [Full Text] [Related]

  • 13. The role of sonography in assessing severity of fetal anemia in Rh- and Kell-isoimmunized pregnancies.
    Chitkara U, Wilkins I, Lynch L, Mehalek K, Berkowitz RL.
    Obstet Gynecol; 1988 Mar; 71(3 Pt 1):393-8. PubMed ID: 3126469
    [Abstract] [Full Text] [Related]

  • 14. Experience with intrauterine transfusions for severe Rh alloimmunization in a developing country.
    Gupte SC, Lulla CP, Kulkarni SS, Korgaonkar SA, Walvekar VR, Merchant RH.
    J Matern Fetal Med; 1998 Mar; 7(6):287-91. PubMed ID: 9848694
    [Abstract] [Full Text] [Related]

  • 15. [Analysis and perinatal outcome after intravascular transfusion].
    Monico-Ramos R, Ochoa-Flores M, Hernández-Herrera RJ, Flores-Pompa E.
    Ginecol Obstet Mex; 2011 Jun; 79(6):351-7. PubMed ID: 21966826
    [Abstract] [Full Text] [Related]

  • 16. Reversion of the Ballantyne syndrome despite fetal hydrops persistence.
    Lobato G, Nakamura-Pereira M.
    Fetal Diagn Ther; 2008 Jun; 24(4):474-7. PubMed ID: 19047795
    [Abstract] [Full Text] [Related]

  • 17. Increased perinatal loss after intrauterine transfusion for alloimmune anaemia before 20 weeks of gestation.
    Lindenburg IT, van Kamp IL, van Zwet EW, Middeldorp JM, Klumper FJ, Oepkes D.
    BJOG; 2013 Jun; 120(7):847-52. PubMed ID: 23551577
    [Abstract] [Full Text] [Related]

  • 18. [Perinatal management and neurological outcome of newborns hospitalized with Rhesus hemolytic disease].
    Gobalakichenane P, Lardennois C, Galène-Gromez S, Brossard V, Marpeau L, Verspyck E, Marret S, le Réseau de périnatalité de Haute-Normandie.
    Gynecol Obstet Fertil; 2008 Oct; 36(10):984-90. PubMed ID: 18804397
    [Abstract] [Full Text] [Related]

  • 19. Prediction of severe fetal anemia in red blood cell alloimmunization after previous intrauterine transfusions.
    Scheier M, Hernandez-Andrade E, Fonseca EB, Nicolaides KH.
    Am J Obstet Gynecol; 2006 Dec; 195(6):1550-6. PubMed ID: 16796991
    [Abstract] [Full Text] [Related]

  • 20. Fetal hemolytic anemia and intrauterine death caused by anti-M immunization.
    Wikman A, Edner A, Gryfelt G, Jonsson B, Henter JI.
    Transfusion; 2007 May; 47(5):911-7. PubMed ID: 17465958
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.